Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy

You may be eligible if

• The patient has not received Vimpat® more than 7 days prior to start of Non-Interventional Study (NIS)
• The patient must have a diagnosis of epilepsy with partial-onset seizures with or without secondary generalization
• Based on the physician's clinical judgment, it is in the patient's best interest to be prescribed adjunctive Vimpat® (ie, the decision to prescribe Vimpat® is made by the physician)
• Patient must be at least 18 years of age
• The patient must have had at least one seizure within the last 3 months prior to enrolment